Cellectis publie ses résultats financiers pour le troisième trimestre et pour les neuf premiers mois de l’année 2021

NEXT STORY
Eledon Pharmaceuticals CEO David-Alexandre C. Gros, M.D., to Present at CareDx Virtual Transplant Innovation Day during ASN Kidney Week 2021
PREV STORY
Cellectis Provides Business Update and Reports Financial Results for Third Quarter and First Nine Months 2021
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Abiomed Receives FDA IDE Approval for Initiation of Door to Unloading (DTU) Prospective Feasibility Study

DANVERS, Mass., Oct. 27, 2016 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider ...

author_avatar
NASDAQ Market News

Curetis Publishes Third Quarter and 9-Month Business and Financial Update

author_avatar
NASDAQ Market News

CORRECTING and REPLACING — Celsion Files Immunotherapy Clinical Protocol for the Evaluation of GEN-1 to Treat Newly Diagnosed Ovarian Cancer

 Expert Advisory Board Endorses Randomized Phase I/II Trial in Newly Diagnosed Stage III and IV ...

author_avatar
NASDAQ Market News